Chemotherapy combined with lenvatinib and PD-1 may be a potential better alternative option for advanced unresectable intrahepatic cholangiocarcinoma: a retrospective real-world study

BackgroundCurrently, the prognosis of advanced intrahepatic cholangiocarcinoma (ICC) is poor, and the current treatment methods are not effective.ObjectiveThe aim of this study was to evaluate the anticancer efficacy of chemotherapy combined with PD-1 inhibitors and tyrosine kinase inhibitors (TKIs)...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Zhitao Dong, Chengjun Sui, Jiongjiong Lu, Junwu Guo, Kecai Duan, Kui Wang, Li Geng, Binghua Dai, Jiamei Yang
Format:	Artigo
Sprog:	Inglês
Udgivet:	Frontiers Media S.A. 2024-09-01
Serier:	Frontiers in Immunology
Fag:	unresectable ICC programmed cell death protein 1 (PD-1) tyrosine kinase PD-1 inhibitor systematic therapy
Online adgang:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1463574/full
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!